Status:

APPROVED_FOR_MARKETING

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Lead Sponsor:

CONKO-Studiengruppe

Collaborating Sponsors:

Sanofi

medac GmbH

Conditions:

Pancreatic Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to compare best supportive care plus oxaliplatin/ folinic acid/ 5-FU versus best supportive alone in patients with gemcitabine refractory pancreatic cancer.

Detailed Description

Gemcitabine (G) given until progressive disease (PD) is still standard therapy in patients with advanced pancreatic cancer. No standard secondline regimen is available after PD. Best supportive care (...

Eligibility Criteria

Inclusion

  • Patients with histologically or cytologically confirmed metastatic pancreatic adenocarcinoma that had progressed during first line gemcitabine therapy were eligible for inclusion in the study.
  • Other inclusion criteria were:
  • Age \> 18 years
  • Karnofsky performance status \> 70%
  • Bidimensionally measurable reference lesion, adequate laboratory values for hematology (white blood cell \[WBC\] count \> 3.5´109/L, platelet count \> 100´109/L), renal function (creatine clearance \> 30 ml/min) and hepatic function (aspartate aminotransferase \[AST\] or alanine aminotransferase \[ALT\] \< 2.5 ´ upper normal limit \[UNL\] and in the case of liver metastasis \< 5 x UNL)
  • As well as controlled pain

Exclusion

  • Patients were excluded from the study if they had any severe concurrent medical condition interfering with planned therapy, serious cardiac disease, sensory/ motor neuropathy \> grade 2 or had previous or current malignancies at other origin; besides, pregnant or lactating women were excluded.
  • All patients provided written informed consent.

Key Trial Info

Start Date :

Trial Type :

EXPANDED_ACCESS

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00786058

Last Update

June 15 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 | DecenTrialz